Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
about
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesRSK2 signaling in brain habenula contributes to place aversion learningRSK2 signaling in medial habenula contributes to acute morphine analgesia.A mouse model of conditional lipodystrophy.Intracellular signalling pathways activated by leptin.Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase.Identification of germ cell-specific genes in mammalian meiotic prophase.Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism.Insulin immuno-neutralization in fed chickens: effects on liver and muscle transcriptome.Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome.Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.Bivariate genome linkage analysis suggests pleiotropic effects on chromosomes 20p and 3p for body fat mass and lean mass.Rsk2 Knockout Affects Emotional Behavior in the IntelliCage.The promise and challenges of targeting RSK for the treatment of cancer.The Human Obesity Gene Map: The 2004 Update
P2860
Q24632768-BD96014B-C30C-4EA9-AD37-1229E8B85460Q35667948-33AD8B94-02E5-4EC4-BB56-B49E03196E91Q35837740-30BEE77C-3F17-4B56-A609-EC3161217C32Q36082198-6289B828-CCDA-4B2D-AF34-2331AB55FC23Q36334963-0FFA8E2F-BFF8-4412-8037-F5F4CEE1441AQ36512262-91BD6C46-7404-40AB-86AA-BF92BCCDBF31Q36689499-A9FD9EDE-046A-4217-A231-921425A29E0AQ37312198-CBCDADF6-1842-4606-BD8B-B0D62380563EQ39668185-72D9E6B2-1DD5-42B2-A8D5-3E5A79B34205Q40474739-626B9B0F-32D6-4CB4-9878-FBBCE60CB780Q42945651-C5DAD660-A775-4CD8-88FC-4B14C497B33EQ43003369-515013A1-5521-45AE-97AA-B3586EFA012CQ47601191-388EB960-30F9-401F-9D00-9E9F7782DC61Q47702480-5310731C-E57F-4944-8E9A-063872A769D7Q50787038-4EF73B0A-423F-41D3-8720-BB5337A4B435Q57316399-80EE71E3-2D97-46D3-9C03-DC92DA9158C0
P2860
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@en
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@nl
type
label
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@en
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@nl
prefLabel
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@en
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@nl
P2093
P1433
P1476
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
@en
P2093
Christian Bjørbaek
Jeffrey S Flier
Karim El-Haschimi
Laurie J Goodyear
Michael F Hirshman
Scott D Dufresne
P304
P356
10.2337/DIABETES.52.6.1340
P407
P577
2003-06-01T00:00:00Z